Site Monitoring
Supporting centralised, decentralised (DCT), virtual and hybrid studies.
Experienced centralised and field (national) CRAs are critical to success. Gaea only has senior CRAs, with minimum experience of around 10-years, with a full understanding of national regulations and with a critical eye for detail.
Our provider’s DCT technology platform is built to seamlessly connect.
When we design and implement DCTs, we provide that seamlessly integrated, technology-enabled solution that reduces patient burden.
Whether you need ePRO solutions or device integrations for digital biomarkers, we are your source.
The technology platform is engineered for patients to engage intuitively. Patients can easily navigate app screens for reminders, alerts, and dosing diaries.
Patients participating in your clinical trial will benefit from in-home sampling services (blood draws, biologic sampling, and urine collection), clinical assessments (vital signs, ECGs, weight), and training on mobile for device/sensor/application use.
Our provider is also experienced at direct-to patient (DTP) transport of IMP, and at home dispensing in more than 120 countries.
Great efforts go into enrolment and dropout rate can increase if patients tire of travel as often as needed in some protocols, but just to be dosed. Where practical, at home dosing will help to retain patients.